Rackow Beth W, Arici Aydin
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, & Reproductive Sciences, Yale University School of Medicine, P.O. Box 208063, New Haven, CT 06520-8063, USA.
Obstet Gynecol Clin North Am. 2006 Mar;33(1):97-113. doi: 10.1016/j.ogc.2005.12.014.
It is evident that complex biochemical interactions are involved in the regulation of myoma growth, and ovarian steroid hormones have significant influence on this process. Current myoma therapies manipulate the hormonal environment to achieve myoma regression and control of bleeding. Although several of these therapies achieve some level of success, further studies are necessary to evaluate the current and long-term effects of these therapies. In clinical medicine each patient must be evaluated thoroughly, and the decision for medical therapy or surgery--and for which medical therapy--needs to be individualized. If one medical therapy does not work, several other effective therapies are available.
显然,复杂的生化相互作用参与了肌瘤生长的调节,而卵巢甾体激素对这一过程有显著影响。目前的肌瘤治疗方法通过操纵激素环境来实现肌瘤缩小和控制出血。尽管其中一些治疗方法取得了一定程度的成功,但仍需要进一步研究来评估这些治疗方法的当前和长期效果。在临床医学中,必须对每位患者进行全面评估,对于药物治疗还是手术治疗——以及采用哪种药物治疗——的决策需要因人而异。如果一种药物治疗无效,还有其他几种有效的治疗方法可供选择。